Research output per year
Research output per year
Personal profile
Research interests
Specializing in Genitourinary Oncology.
Clinical interests
Oncology, genitourinary oncology, solid tumor oncology, cancer, medical oncology, testicular cancer, germ cell tumors, kidney cancer, renal cell carcinoma, bladder cancer, and renal pelvis tumors.
Fingerprint
Dive into the research topics where Bruce Roth is active. These topic labels come from the works of this person and are generated automatically. Together they form a unique fingerprint. Contact the Profiles team with questions.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial)
Morris, M. J., Heller, G., Hillman, D. W., Bobek, O., Ryan, C., Antonarakis, E. S., Bryce, A. H., Hahn, O., Beltran, H., Armstrong, A. J., Schwartz, L., Lewis, L. D., Beumer, J. H., Langevin, B., Mcgary, E. C., Mehan, P. T., Goldkorn, A., Roth, B. J., Xiao, H. & Watt, C. & 3 others, , Jun 20 2023, In: Journal of Clinical Oncology. 41, 18, p. 3352-3362 11 p.Research output: Contribution to journal › Article › peer-review
Open Access21 Scopus citations -
Association Between Local Radiation Therapy to the Primary Bladder Tumor and Overall Survival for Patients with Metastatic Urothelial Cancer Receiving Systemic Chemotherapy
Fischer-Valuck, B. W., Patel, S. A., Brenneman, R. J., Christodouleas, J., Sargos, P., Kim, E., Weiss, A., Hershatter, B., Rao, Y. J., Picus, J., Roth, B., Arora, V., Carmona, R., Reimers, M., Zaghloul, M. S., Gay, H., Michalski, J. M. & Baumann, B. C., Apr 1 2022, In: European Urology Oncology. 5, 2, p. 246-250 5 p.Research output: Contribution to journal › Article › peer-review
Open Access11 Scopus citations -
Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216)
Agarwal, N., Tangen, C. M., Hussain, M. H. A., Gupta, S., Plets, M., Lara, P. N., Harzstark, A. L., Twardowski, P. W., Paller, C. J., Zylla, D., Zibelman, M. R., Levine, E., Roth, B. J., Goldkorn, A., Vaena, D. A., Kohli, M., Crispino, T., Vogelzang, N. J., Thompson, I. M. & Quinn, D. I., Apr 1 2022, In: Journal of Clinical Oncology. 6, JCO.21.02517.Research output: Contribution to journal › Article › peer-review
Open Access36 Scopus citations -
Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent Chemoradiotherapy
Fischer-Valuck, B. W., Michalski, J. M., Harton, J. G., Birtle, A., Christodouleas, J. P., Efstathiou, J. A., Arora, V. K., Kim, E. H., Knoche, E. M., Pachynski, R. K., Picus, J., Rao, Y. J., Reimers, M., Roth, B. J., Sargos, P., Smith, Z. L., Zaghloul, M. S., Gay, H. A., Patel, S. A. & Baumann, B. C., Feb 2021, In: Clinical Genitourinary Cancer. 19, 1, p. 41-46.e1Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Vorolanib (X-82), an oral anti-VEGFR/PDGFR/CSF1R tyrosine kinase inhibitor, with everolimus in solid tumors: results of a phase I study
Pedersen, K. S., Grierson, P. M., Picus, J., Lockhart, A. C., Roth, B. J., Liu, J., Morton, A., Chan, E., Huffman, J., Liang, C., Wang-Gillam, A. & Tan, B., Oct 2021, In: Investigational New Drugs. 39, 5, p. 1298-1305 8 p.Research output: Contribution to journal › Article › peer-review
28 Scopus citations